IDEXX Laboratories

IDEXX Laboratories

Quarterly Financials

Values in thousands2026-06-302026-03-312025-12-312025-09-30
Revenue
$1,216,585
$1,140,820
$1,090,579
$1,105,239
Gross Profit
779,087
722,739
658,114
683,354
EBITDA
468,457
400,866
356,219
392,053
EBIT
427,406
363,183
317,498
355,426
Net Income
338,412
278,446
248,188
274,610
Net Change In Cash
1,216,585
1,140,820
1,090,579
1,105,239
Free Cash Flow
322,516
234,264
322,588
371,226
Cash
196,933
200,528
180,070
208,166
Basic Shares
80,675
80,675
80,675
80,675

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$4,303,702
$3,897,504
$3,660,953
$3,367,324
Gross Profit
2,659,579
2,378,927
2,189,970
2,004,338
EBITDA
1,468,916
1,275,840
1,097,128
1,010,665
EBIT
1,362,454
1,145,904
1,097,128
898,765
Net Income
1,059,464
887,867
845,042
679,089
Net Change In Cash
4,303,702
3,897,504
3,660,953
3,367,324
Cost of Revenue
-23,302
Free Cash Flow
1,053,391
798,079
772,879
394,146
Cash
180,070
288,266
453,932
112,546
Basic Shares
80,675
83,056
83,978
84,600

Earnings Calls

QuarterEPS
2026-06-30
$4.27
2026-03-31
$3.47
2025-12-31
$3.08
2025-09-30
$3.40